COPD: risk factors, biomarkers and diagnosis

Oral Presentation
Chairs: J. Garcia Aymerich (Barcelona, Spain), P. Burney (London, United Kingdom)

LATE-BREAKING ABSTRACT: Respiratory health at the extremes of the ageing population: Initial results of the UK Newcastle 85+ study T. Small, J. Collerton, K. Davies, M. Yadegarfar, T. Kirkwood, P. Corris, A. Fisher (Newcastle upon Tyne, United Kingdom)
Passive smoking and COPD – More dangerous than believed S. Hagstad, L. Ekerljung, A. Bjerg, A. Lindberg, E. Rönmark, B. Lundbäck (Luleå, Sweden)
The effect of body mass on COPD in non-smoking women T. Schikowski, M. Adam, A. Vierkötter, B. Hoffmann, U. Krämer, T. Rochat, C. Schindler, E. Zemp, N. Künzli, N. Probst-Hensch (Basel, Geneva, Switzerland; Duesseldorf, Germany)
COPD – Prevalence and risk study from rural north India M. Singh, A.K. Mukherjee, S.K. Ahluwalia, A. Bhardwaj, S. Saini (Mullana, India)
Association between serum levels of clara cell secretory protein and lung function in adults from ECRHS M. Rava, L. Tares, I. Lavi, E. Barreiro, J.P. Zock, A. Ferrer, N. Muniozguren, R. Nadif, F. Kauffmann, J.M. Anto, S. Guerra (Barcelona, Bilbao, Spain; Villejuif, France)
Screening of citizens with suspicion of COPD in eight municipalities in Denmark J. Dollerup, T. Jakobsen, H. Fischer, U. Hemmingsen, S. Ollendorff, J. Madsen, M.B. Gulstad, H. Borggren, B. Kvist, P.B. Poulsen (Ballerup, Esbjerg, Struer, Vordingborg, Kolding, Helsinge, Brovst, Solrød, Frederikshavn, Denmark)
Is spirometry properly used to diagnose COPD? Results from the population-based BOLD study in Salzburg, Austria B. Lamprecht, A. Mahringer, B. Kaiser, J. Soriano, M. Studnicka (Salzburg, Austria; Bunyola, Spain)
Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD J. Thornton Snider, Y. Luna, K. Wong, J. Zhang, S. Chen, D. Goldman (Los Angeles, East Hanover, United States Of America)